Corporate information
Registration country
Company type
Venture capital fund investing in biotech, medtech and diagnostic companies across Europe with a special interest in Spain.Overview
EUR 100,000,000 target (USD 138,000,000)
Fund terms
Fund manager
Vintage
2015
Fund type
Currency
European Union Euro
Extension comment
Planned end date of 30 Sep 2024.
Funding rounds
Fund Closing EUR 126,400,000
USD 139,100,000 ( )
Ysios BioFund II Innvierte institutional investors include: CDTI (Spanish Ministry of Economy) through its Innvierte program; the European Investment Fund (EIF) and the European Commission through InnovFin SME Venture Capital, a financial instrument devel
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Banco de Sabadell SA (Banco Sabadell) | Spanish banking group located in Sabadell | Initial investment. | |
|
Centre for the Development of Industrial Technology (CDTI) | Business entity run by the Ministry of the Economy and Competitiveness aiming to enhance the scientific and technical expertise of Spanish businesses. | Initial investment. | |
|
European Investment Fund (EIF) | European Union agency, headquartered in Luxembourg, for the provision of finance to small and medium-sized enterprises. | Initial investment. (IFE Facility for Early Stage, InnovFin) | |
|
Ysios Capital Partners SGECR SA | Spanish venture capital firm focused on the healthcare space. | Initial investment. (2%) |
Investment preferences
Industry focus comment
Life sciences.
Stage focus summary
Early Stage (Seed, Start-up and other)
Stage focus
Investment activity status
Active investor